Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
16.9 (1y: +14%)
Market Cap 2.73 B P/E(ttm) 41.60
Enterprise Value 2.87 B P/B 4.00
BRKR- NAS (USA)
Bruker Corporation
  • Currently 4.5/5
Business Predictability Rank: 4.5-Star (On Watch)
Back Testing Results:
Average gain of all 4.5-Star stocks: 10.6% per year.
% of Stocks that are in still loss if held for 10yrs: 10%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$16.90
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry		 vs
history
Cash to Debt 0.921
BRKR's Cash to Debt is ranked lower than
62% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 118.50 vs. BRKR: 0.921 )
BRKR' s 10-Year Cash to Debt Range
Min: 0.16   Max: 7.86
Current: 0.92
0.16
7.86
Equity to Asset 0.255
BRKR's Equity to Asset is ranked lower than
87% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.54 vs. BRKR: 0.255 )
BRKR' s 10-Year Equity to Asset Range
Min: 0.14   Max: 0.67
Current: 0.26
0.14
0.67
Interest Coverage 11.6
BRKR's Interest Coverage is ranked higher than
52% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 10000.00 vs. BRKR: 11.6 )
BRKR' s 10-Year Interest Coverage Range
Min: 4   Max: No Debt
Current: 11.6
F-Score: 5
Z-Score: 3.09
M-Score: -2.61
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry		 vs
history
Operating margin (%) 8.70
BRKR's Operating margin (%) is ranked higher than
92% of the 1946 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 3.80 vs. BRKR: 8.70 )
BRKR' s 10-Year Operating margin (%) Range
Min: -3.7   Max: 12.3
Current: 8.7
-3.7
12.3
Net-margin (%) 4.3
BRKR's Net-margin (%) is ranked higher than
89% of the 1946 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.70 vs. BRKR: 4.3 )
BRKR' s 10-Year Net-margin (%) Range
Min: -6.7   Max: 7.3
Current: 4.3
-6.7
7.3
ROE (%) 11
BRKR's ROE (%) is ranked higher than
96% of the 1946 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 5.30 vs. BRKR: 11 )
BRKR' s 10-Year ROE (%) Range
Min: -8.7   Max: 20.8
Current: 11
-8.7
20.8
ROA (%) 4.2
BRKR's ROA (%) is ranked higher than
92% of the 1946 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 3.00 vs. BRKR: 4.2 )
BRKR' s 10-Year ROA (%) Range
Min: -5   Max: 6.9
Current: 4.2
-5
6.9
ROC (Joel Greenblatt) (%) 25.90
BRKR's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 1946 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 8.80 vs. BRKR: 25.90 )
BRKR' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -5.9   Max: 36.8
Current: 25.9
-5.9
36.8
Revenue Growth (%) 12.2
BRKR's Revenue Growth (%) is ranked higher than
95% of the 1946 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.65 vs. BRKR: 12.2 )
BRKR' s 10-Year Revenue Growth (%) Range
Min: 7.3   Max: 20.4
Current: 12.2
7.3
20.4
EBITDA Growth (%) 6.1
BRKR's EBITDA Growth (%) is ranked higher than
95% of the 1946 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 3.25 vs. BRKR: 6.1 )
BRKR' s 10-Year EBITDA Growth (%) Range
Min: -12.4   Max: 55.9
Current: 6.1
-12.4
55.9
EPS Growth (%) -1.6
BRKR's EPS Growth (%) is ranked higher than
89% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 4.80 vs. BRKR: -1.6 )
BRKR' s 10-Year EPS Growth (%) Range
Min: -1.6   Max: 76.7
Current: -1.6
-1.6
76.7
ยป BRKR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

BRKR Guru Trades in Q2 2012

Paul Tudor Jones 32,300 sh (New)
Jim Simons 187,410 sh (+65.25%)
Steven Cohen 47,248 sh (-12.07%)
» More
Q3 2012

BRKR Guru Trades in Q3 2012

Joel Greenblatt 244,897 sh (New)
Steven Cohen 61,691 sh (+30.57%)
Paul Tudor Jones Sold Out
Jim Simons 13,210 sh (-92.95%)
» More
Q4 2012

BRKR Guru Trades in Q4 2012

Louis Moore Bacon 106,795 sh (New)
Paul Tudor Jones 14,700 sh (New)
Steven Cohen 202,388 sh (+228.07%)
Jim Simons Sold Out
Joel Greenblatt 38,498 sh (-84.28%)
» More
Q1 2013

BRKR Guru Trades in Q1 2013

Vanguard Health Care Fund 806,758 sh (New)
RS Investment Management 1,085,810 sh (New)
Paul Tudor Jones 16,700 sh (+13.61%)
Louis Moore Bacon Sold Out
Joel Greenblatt 33,383 sh (-13.29%)
Steven Cohen 82,517 sh (-59.23%)
» More
» Details

Insider Trades

Latest Guru Trades with BRKR

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Vanguard Health Care Fund 2013-03-31 New Buy0.06%$15.238 - $19.1 $ 17.360%806758
Joel Greenblatt 2012-12-31 Reduce -84.28%0.18%$11.77 - $15.54 $ 17.3626%38498
Joel Greenblatt 2012-09-30 New Buy0.21%$11.34 - $14.13 $ 17.3637%244897
Joel Greenblatt 2011-06-30 Sold Out 0.1%$17.36 - $21.44 $ 17.36-10%0
Joel Greenblatt 2011-03-31 Add 27.81%0.02%$16 - $20.6 $ 17.36-5%16567
Mario Gabelli 2011-03-31 Sold Out $16 - $20.6 $ 17.36-5%0
Joel Greenblatt 2010-12-31 New Buy0.07%$14.14 - $17.46 $ 17.3611%12962
George Soros 2010-09-30 Sold Out $10.88 - $14.32 $ 17.3636%0
George Soros 2010-06-30 New Buy$11.97 - $15.56 $ 17.3626%11800
Premium More recent guru trades are included for Premium Members only!!

Top Ranked Articles about Bruker Corporation

Weekly CEO Buys Highlight: NGL, BRKR, UTHR, KTOS, GBL
December 24, 2012
According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below: Read more...

Ratios

vs
industry		 vs
history
P/E(ttm) 41.60
BRKR's P/E(ttm) is ranked higher than
73% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 20.31 vs. BRKR: 41.60 )
BRKR' s 10-Year P/E(ttm) Range
Min: 8.49   Max: 652
Current: 41.6
8.49
652
P/B 4.00
BRKR's P/B is ranked lower than
86% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.23 vs. BRKR: 4.00 )
BRKR' s 10-Year P/B Range
Min: 1.19   Max: 10.78
Current: 4
1.19
10.78
P/S 1.60
BRKR's P/S is ranked lower than
75% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.73 vs. BRKR: 1.60 )
BRKR' s 10-Year P/S Range
Min: 0.53   Max: 14.56
Current: 1.6
0.53
14.56
PFCF 88.90
BRKR's PFCF is ranked lower than
66% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 13.74 vs. BRKR: 88.90 )
BRKR' s 10-Year PFCF Range
Min: 10.09   Max: 198
Current: 88.9
10.09
198
EV-to-EBIT 21.3
BRKR's EV-to-EBIT is ranked higher than
84% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 15.40 vs. BRKR: 21.3 )
BRKR' s 10-Year EV-to-EBIT Range
Min: 6.2   Max: 1712.3
Current: 21.3
6.2
1712.3
PEG 3.6
BRKR's PEG is ranked higher than
97% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.50 vs. BRKR: 3.6 )
BRKR' s 10-Year PEG Range
Min: 0.15   Max: 78.62
Current: 3.6
0.15
78.62
Shiller P/E 33.1
BRKR's Shiller P/E is ranked higher than
88% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 21.15 vs. BRKR: 33.1 )
BRKR' s 10-Year Shiller P/E Range
Min: 22.63   Max: 308.8
Current: 33.1
22.63
308.8

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 5.6
BRKR's Price/Net Current Asset Value is ranked higher than
85% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 4.10 vs. BRKR: 5.6 )
BRKR' s 10-Year Price/Net Current Asset Value Range
Min: 2   Max: 42.1
Current: 5.6
2
42.1
Price/Tangible Book 6.1
BRKR's Price/Tangible Book is ranked higher than
95% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.40 vs. BRKR: 6.1 )
BRKR' s 10-Year Price/Tangible Book Range
Min: 1.7   Max: 9.7
Current: 6.1
1.7
9.7
Price/DCF (Projected) 1.9
BRKR's Price/DCF (Projected) is ranked higher than
94% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.10 vs. BRKR: 1.9 )
BRKR' s 10-Year Price/DCF (Projected) Range
Min: 1.2   Max: 6.2
Current: 1.9
1.2
6.2
Price/Median PS Value 0.9
BRKR's Price/Median PS Value is ranked higher than
86% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.80 vs. BRKR: 0.9 )
BRKR' s 10-Year Price/Median PS Value Range
Min: 0.3   Max: 6.7
Current: 0.9
0.3
6.7
Price/Peter Lynch Fair Value 3.6
BRKR's Price/Peter Lynch Fair Value is ranked higher than
96% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.70 vs. BRKR: 3.6 )
BRKR' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.4   Max: 18.7
Current: 3.6
0.4
18.7
Price/Graham Number 3.2
BRKR's Price/Graham Number is ranked higher than
89% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.10 vs. BRKR: 3.2 )
BRKR' s 10-Year Price/Graham Number Range
Min: 1.1   Max: 15.6
Current: 3.2
1.1
15.6
Earnings Yield (Greenblatt) 4.70
BRKR's Earnings Yield (Greenblatt) is ranked higher than
90% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 5.45 vs. BRKR: 4.70 )
BRKR' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 16.2
Current: 4.7
0.1
16.2
Forward Rate of Return (Yacktman) 14.31
BRKR's Forward Rate of Return (Yacktman) is ranked higher than
95% of the 1561 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 3.01 vs. BRKR: 14.31 )
BRKR' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -1.7   Max: 62.9
Current: 14.31
-1.7
62.9

Business Description

Bruker Corporation is a global manufacturer of scientific instruments that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications. Its technology platforms include magnetic resonance technologies, mass spectrometry technologies, gas chromatography technologies, X-ray technologies, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology technology and infrared and Raman molecular spectroscopy technologies. It also manufacture and distribute a range of field analytical systems for chemical, biological, radiological and nuclear, or CBRN, detection as well as superconducting wire products and devices. The company's five operating segments are: Bruker BioSpin, Bruker Daltonics, Bruker MAT, Bruker Optics, and Bruker Energy & Supercon Technologies. Bruker BioSpin is in the business of designing, manufacturing and distributing life science tools based on magnetic resonance technology. Bruker Daltonics is in the business of designing, manufacturing, and distributing mass spectrometry and gas chromatography instruments and solutions for life sciences, including proteomics, metabolomics, and clinical research applications. Its mass spectrometry and gas chromatography instruments also provide solutions for applied markets that include food safety, environmental analysis and fuel analysis. Bruker Daltonics also designs, manufactures, and distributes various analytical instruments for CBRNE detection. Bruker MAT, or materials research, analysis and metrology, is in the business of designing, manufacturing, and distributing advanced X-ray, spark optical emission spectroscopy, combustion analysis, atomic force microscopy and stylus and optical metrology instrumentation used in molecular, materials, and elemental analysis. Bruker Optics is in the business of designing, manufacturing, and distributing research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. Bruker Energy & Supercon Technologies is in the business of developing and producing superconducting materials and devices based primarily on metallic low temperature superconductors and ceramic high temperature superconductors with applications in renewable energy, energy infrastructure, medical imaging and life science analytics and "big science" research, which typically consists of large scale projects funded by a government or a group of governments. For financial reporting purposes, the Company has combined the Bruker BioSpin, Bruker Daltonics, Bruker MAT and Bruker Optics operating segments into the Scientific Instruments reporting segment because each has similar economic characteristics, product processes and services, types and classes of customers, methods of distribution, and
Company Website
SEC Reports
Industry: Scientific & Technical Instruments
Compare:A, ROP, GRMN, HXGBY, TRMB
Traded in other countries:BKD.Germany
ยป More Articles for BRKR

Headlines

Articles On GuruFocus.com
Weekly CEO Buys Highlight: NGL, BRKR, UTHR, KTOS, GBL Dec 24 2012 
Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 10,000 Shares Mar 17 2011 
Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 1,220 Shares Mar 03 2011 
Weekly CEO Buys Highlight: Deer Consumer Products, Dynex Capital, Bruker BioSciences Corp, American Mar 27 2010 
Weekly CEO Buys Highlight: Bruker BioSciences Corp, Dynex Capital Inc, American Dairy Inc, Pioneer D Mar 21 2010 
Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 100,000 Shares Mar 18 2010 
Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 100,000 Shares Mar 15 2010 
Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 3,570 Shares Dec 15 2009 
Weekly CEO Buy Highlights: Bruker BioSciences Corp, Cousins Properties Inc, FIFTH STREET FINANCE, La Sep 27 2009 
Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 100,000 Shares Sep 23 2009 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial